These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 24194435)

  • 1. Prucalopride: a review of its use in the management of chronic constipation.
    Keating GM
    Drugs; 2013 Nov; 73(17):1935-50. PubMed ID: 24194435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prucalopride: A Review in Chronic Idiopathic Constipation.
    Garnock-Jones KP
    Drugs; 2016 Jan; 76(1):99-110. PubMed ID: 26628294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A placebo-controlled trial of prucalopride for severe chronic constipation.
    Camilleri M; Kerstens R; Rykx A; Vandeplassche L
    N Engl J Med; 2008 May; 358(22):2344-54. PubMed ID: 18509121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, double-blind, placebo-controlled, phase 3 trial to evaluate the efficacy, safety, and tolerability of prucalopride in men with chronic constipation.
    Yiannakou Y; Piessevaux H; Bouchoucha M; Schiefke I; Filip R; Gabalec L; Dina I; Stephenson D; Kerstens R; Etherson K; Levine A
    Am J Gastroenterol; 2015 May; 110(5):741-8. PubMed ID: 25869393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic review with meta-analysis: highly selective 5-HT4 agonists (prucalopride, velusetrag or naronapride) in chronic constipation.
    Shin A; Camilleri M; Kolar G; Erwin P; West CP; Murad MH
    Aliment Pharmacol Ther; 2014 Feb; 39(3):239-53. PubMed ID: 24308797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of prucalopride in adults with chronic idiopathic constipation.
    Vijayvargiya P; Camilleri M
    Expert Rev Clin Pharmacol; 2019 Jul; 12(7):579-589. PubMed ID: 31096799
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical trial: the efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation--a 12-week, randomized, double-blind, placebo-controlled study.
    Quigley EM; Vandeplassche L; Kerstens R; Ausma J
    Aliment Pharmacol Ther; 2009 Feb; 29(3):315-28. PubMed ID: 19035970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of prucalopride on symptoms of chronic constipation.
    Tack J; Stanghellini V; Dubois D; Joseph A; Vandeplassche L; Kerstens R
    Neurogastroenterol Motil; 2014 Jan; 26(1):21-7. PubMed ID: 24106924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between health-related quality of life and symptoms in patients with chronic constipation: an integrated analysis of three phase 3 trials of prucalopride.
    Tack J; Camilleri M; Dubois D; Vandeplassche L; Joseph A; Kerstens R
    Neurogastroenterol Motil; 2015 Mar; 27(3):397-405. PubMed ID: 25581251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxatives.
    Tack J; van Outryve M; Beyens G; Kerstens R; Vandeplassche L
    Gut; 2009 Mar; 58(3):357-65. PubMed ID: 18987031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of prucalopride in adults and children with chronic constipation.
    Diederen K; Mugie SM; Benninga MA
    Expert Opin Pharmacother; 2015 Feb; 16(3):407-16. PubMed ID: 25539475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prucalopride.
    Frampton JE
    Drugs; 2009; 69(17):2463-76. PubMed ID: 19911858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prucalopride. In chronic constipation: poorly documented risks.
    Prescrire Int; 2011 May; 20(116):117-20. PubMed ID: 21648173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and Safety of Prucalopride in Chronic Constipation: An Integrated Analysis of Six Randomized, Controlled Clinical Trials.
    Camilleri M; Piessevaux H; Yiannakou Y; Tack J; Kerstens R; Quigley EMM; Ke M; Da Silva S; Levine A
    Dig Dis Sci; 2016 Aug; 61(8):2357-2372. PubMed ID: 27056037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, double-blind, placebo-controlled trial to evaluate the efficacy, safety, and tolerability of long-term treatment with prucalopride.
    Piessevaux H; Corazziari E; Rey E; Simren M; Wiechowska-Kozlowska A; Kerstens R; Cools M; Barrett K; Levine A
    Neurogastroenterol Motil; 2015 Jun; 27(6):805-15. PubMed ID: 25808103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral prucalopride in children with functional constipation.
    Winter HS; Di Lorenzo C; Benninga MA; Gilger MA; Kearns GL; Hyman PE; Vandeplassche L; Ausma J; Hoppenbrouwers M
    J Pediatr Gastroenterol Nutr; 2013 Aug; 57(2):197-203. PubMed ID: 23535761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Some practical questions on chronic stipsis treatment with prucalopride].
    Bellacosa L; Cogliandro R; Cremon C; De Giorgio R; Barbara G; Stanghellini V
    Minerva Gastroenterol Dietol; 2014 Mar; 60(1):85-99. PubMed ID: 24632771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prucalopride succinate for the treatment of constipation: an update.
    Bassotti G; Gambaccini D; Bellini M
    Expert Rev Gastroenterol Hepatol; 2016; 10(3):291-300. PubMed ID: 26647167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prucalopride: evaluation of the pharmacokinetics, pharmacodynamics, efficacy and safety in the treatment of chronic constipation.
    Tack J; Corsetti M
    Expert Opin Drug Metab Toxicol; 2012 Oct; 8(10):1327-35. PubMed ID: 22985444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prucalopride (Motegrity) for chronic idiopathic constipation.
    Med Lett Drugs Ther; 2019 Jun; 61(1573):86-88. PubMed ID: 31170120
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.